To elucidate if the re-expression of these three UGT family members was specific for temozolomide or if this observed response may be a general mechanism for melanoma to defend itself against chemotherapeutics, the anti-cancer agents adriamycin and epirubicin were also examined. Here, SLC35A2 is linked to melanoma.